Compare Roundhill Russell 2000 0DTE Covered Call Strat ETF (RDTE) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roundhill Russell 2000 0DTE Covered Call Strat ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $25.96 (market cap $176.64M), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 142× Roundhill Russell 2000 0DTE Covered Call Strat ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Roundhill Russell 2000 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roundhill Russell 2000 0DTE Covered Call Strat ETF for 53 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| RDTE | ROIV | |
|---|---|---|
Market Cap | $176.64M | $25.09B |
Volume | 116,818 | 5,738,571 |
Sector | Income / Options Overlay | Health |
52-Week High | $33.66 | $41.81 |
52-Week Low | $25.96 | $16.04 |
Typical Hold Time | 53 Days | 0 Days |
Enterprise Value | — | $21.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Roundhill Russell 2000 0DTE Covered Call Strat ETF
RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
